Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) General Counsel Philip Mazzara sold 42,090 shares of Astera Labs stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $40.43, for a total value of $1,701,698.70. Following the sale, the general counsel now owns 333,474 shares in the company, valued at approximately $13,482,353.82. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.
Philip Mazzara also recently made the following trade(s):
- On Monday, August 26th, Philip Mazzara sold 8,000 shares of Astera Labs stock. The stock was sold at an average price of $43.12, for a total value of $344,960.00.
Astera Labs Price Performance
Shares of NASDAQ:ALAB opened at $43.00 on Tuesday. Astera Labs, Inc. has a 52 week low of $36.22 and a 52 week high of $95.21. The firm has a 50-day moving average price of $50.33.
Analysts Set New Price Targets
Several equities research analysts have recently weighed in on the company. Needham & Company LLC decreased their price objective on Astera Labs from $85.00 to $65.00 and set a “buy” rating for the company in a report on Wednesday, August 7th. Craig Hallum decreased their price target on shares of Astera Labs from $90.00 to $75.00 and set a “buy” rating for the company in a research note on Wednesday, August 7th. Deutsche Bank Aktiengesellschaft lowered their price objective on shares of Astera Labs from $85.00 to $60.00 and set a “buy” rating on the stock in a research report on Wednesday, August 7th. Evercore ISI reduced their target price on shares of Astera Labs from $98.00 to $80.00 and set an “outperform” rating for the company in a report on Wednesday, August 7th. Finally, Morgan Stanley lowered their price target on Astera Labs from $85.00 to $55.00 and set an “equal weight” rating on the stock in a report on Wednesday, August 7th. One research analyst has rated the stock with a hold rating and ten have issued a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $71.36.
View Our Latest Stock Analysis on Astera Labs
Institutional Investors Weigh In On Astera Labs
A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Amalgamated Bank purchased a new position in shares of Astera Labs in the 2nd quarter valued at about $74,000. Massachusetts Financial Services Co. MA grew its position in Astera Labs by 2.6% during the second quarter. Massachusetts Financial Services Co. MA now owns 91,408 shares of the company’s stock worth $5,531,000 after buying an additional 2,343 shares during the period. Legato Capital Management LLC purchased a new position in Astera Labs in the second quarter valued at about $207,000. Alpine Global Management LLC acquired a new stake in shares of Astera Labs during the 1st quarter valued at approximately $272,000. Finally, Strategic Blueprint LLC purchased a new stake in shares of Astera Labs during the 2nd quarter worth approximately $332,000.
Astera Labs Company Profile
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
Featured Stories
- Five stocks we like better than Astera Labs
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Why the Buy-and-Hold Strategy May Be Best for Most Investors
- How to Calculate Stock Profit
- Eli Lilly’s Path to the Next Trillion Market Capitalization
- What is Insider Trading? What You Can Learn from Insider Trading
- Mobileye Global: CEO Makes $10 Million Bet on Future Strength
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.